A statewide research initiative launched by the Duke Division of Pulmonology, Allergy and Critical Care Medicine will analyze the biological history of COVID-19, its impact in North Carolina and beyond, and explore potential treatment options. In addition to the pulmonary team, the multidisciplinary project includes representatives from Duke Health Pathology, Duke Health Clinical Laboratories, and the Human Vaccine Institute. Other specialties will help analyze biospecimens. More than 15 Duke Health laboratories are involved in tissue analysis.
The effort is the first broadly based, coronavirus-focused research project in the state, says Patty Lee, MD, chief of the Division of Pulmonology, Allergy and Critical Care Medicine. The project will accelerate scientists’ understanding of the effects of coronavirus and may lead to new therapies, she says.
Keep reading on Clinical Practice Today.